References
- Munro SC, Hall B, Whybin LR, et al Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 2005; 43: 4713–4718.
- Lagrou K, Bodeus M, Van Ranst M. Evaluation of the new ARCHITECT CMV IgM, IgG and IgG Avidity assays. J Clin Microbiol 2009; 47: 1695–1699.
- Revello MG, Gorini G, Gerna G, et al Clinical evaluation of a chemiluminescence for determination of immunoglobulin G avidity to human cytomegalovirus. Clin Diagn Lab Immunol 2004; 11: 801–805.
- Enders G, Bader U, Daiminger A, et al Serodiagnosis of cytomegalovirus infection in pregnancy using an automated CMV IgM immunoassay that employs native viral proteins and the recombinant DNA-binding protein p52. IBS 2000; 15: 43–46.
- Weber B, Berger A, Rabenau H, et al Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection. J Virol Methods 2001; 96: 157–170.
- Busse C, Strubel A, Schnitzler P, et al Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies. J Clin Virol 2008; 43: 137–141.
- Daiminger A, Bäder U, Eggers M, et al Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women. J Clin Virol 1999; 13: 161–171.
- Plachter B, Klages S, Hagelmann S, et al Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses. J Clin Microbiol 1990; 28: 1229–1235.
- Daiminger A, Bäder U, Enders G. An enzyme linked immunoassay using recombinant antigens for differentiation of primary from secondary or past CMV infections in pregnancy. J Clin Virol 1998; 11: 93–102.
- Inouye S, Hasegawa A, Matsuno S, et al Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol 2000; 38: 1476–1481.
- Maine T, Stricker RM, Schuler M, et al Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J Clin Microbiol 2000; 38: 1476–1481.
- Roche Diagnostics. Elecsys Immunoassay CMV IgG. Australia: Roche Diagnostics, 2008.
- Abbott Diagnostics. Architect CMV IgG. Ireland: Abbott Diagnostics Division, 2007.
- Bland J, Altman D. Measurment in medicine: the analysis of method comparison studies. Statistician 1983; 32: 307–317.
- Anthony V, Joanne G, Garrett J, et al Understanding interobserver agreement: the kappa statistic. Fam Med 2005; 37: 360–363.
- Lazzarotto T, Galli C, Pulvirenti R. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn Lab Immunol 2001; 8: 196–198.
- Pedneault L, Robillard L, Harvey P, et al Comparison of four enzyme immunoassays for the detection of cytomegalovirus IgG antibodies. Clin Diagn Virol 1993; 1: 215–223.
- Sipewa M, Goubau P, Bodéus M, et al Evaluation of a cytomegalovirus glycoprotein B recombinant enzyme immunoassay to discriminate between a recent and a past infection. J Clin Microbiol 2002; 40: 3689–3693.
- Baccard-Longere M, Freymuth F, Cointe D, et al Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin Diagn Lab Immunol 2001; 8: 429–431.
- Bernard W, Hadji M, Bargane F, et al Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens. J Clin Virol 1999; 14: 173–181.
- Dangel V, Ursula Bäder U, Enders G, et al Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples. J Clin Virol 2006; 35: 305–309.
- Hopson D, Niles A, Murray P, et al Comparison of the Vitek Immunodiagnostic Assay System with three immunoassay systems for detection of cytomegalovirus-specific immunoglobulin G. J Clin Microbiol 1992; 30: 2893–2825.
- Busch DH, Pamer EG. T cell affinity maturation by selective expansion during infection. J Exp Med 1999; 189: 701–710.